We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+0.32%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.86%
AUM
$5.94B
AUM Growth
-$289M
Cap. Flow
-$192M
Cap. Flow %
-3.24%
Top 10 Hldgs %
34.62%
Holding
127
New
5
Increased
49
Reduced
62
Closed
6

Top Sells

Rank Stock Value
1
TREX icon
Trex
TREX
+$97.9M
2
SPSC icon
SPS Commerce
SPSC
+$59.2M
3
MLAB icon
Mesa Laboratories
MLAB
+$28.6M
4
ESE icon
ESCO Technologies
ESE
+$20.6M
5
GNRC icon
Generac Holdings
GNRC
+$19M

Sector Composition

Rank Sector Weight
1 Industrials 43.51%
2 Technology 29.05%
3 Healthcare 13.87%
4 Materials 6.41%
5 Consumer Discretionary 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WST icon
51
West Pharmaceutical
WST
$24.9B
$33.8M 0.57%
122,791
+22,008
+22% +$6.02M
POOL icon
52
Pool Corp
POOL
$7.5B
$33.1M 0.56%
144,707
+21,298
+17% +$5.54M
JBTM
53
JBT Marel
JBTM
$6.39B
$28.4M 0.48%
188,602
+15,036
+9% +$2.12M
PCOR icon
54
Procore
PCOR
$8.67B
$28M 0.47%
385,193
+72,481
+23% +$5.36M
LCII icon
55
LCI Industries
LCII
$2.65B
$23.6M 0.4%
194,833
+23,269
+14% +$2.48M
BMI icon
56
Badger Meter
BMI
$4.03B
$22.7M 0.38%
+130,393
New +$23.5M
PCTY icon
57
Paylocity
PCTY
$7.98B
$21.5M 0.36%
141,220
+15,357
+12% +$2.28M
EVI icon
58
EVI Industries
EVI
$180M
$21.5M 0.36%
872,555
+65,885
+8% +$1.64M
TECH icon
59
Bio-Techne
TECH
$11.3B
$20.9M 0.35%
354,561
+49,078
+16% +$2.98M
PLMR icon
60
Palomar
PLMR
$3.45B
$2.78M 0.05%
20,635
+3,050
+17% +$372K
MAMA icon
61
Mama's Creations
MAMA
$833M
$2.51M 0.04%
185,700
-43,540
-19% -$500K
UTI icon
62
Universal Technical Institute
UTI
$1.59B
$2.3M 0.04%
88,140
+4,970
+6% +$141K
WLDN icon
63
Willdan Group
WLDN
$1.3B
$2.12M 0.04%
20,412
-2,326
-10% -$229K
ELVA
64
Electrovaya
ELVA
$481M
$2.08M 0.04%
+263,320
New +$1.59M
IRMD icon
65
iRadimed
IRMD
$1.18B
$2.06M 0.03%
21,215
-6,160
-23% -$528K
BLFS icon
66
BioLife Solutions
BLFS
$1.7B
$1.9M 0.03%
78,492
+2,990
+4% +$78.2K
BWMN icon
67
Bowman Consulting
BWMN
$477M
$1.89M 0.03%
57,295
+1,200
+2% +$45.5K
NABL icon
68
N-able
NABL
$940M
$1.89M 0.03%
252,775
+43,930
+21% +$335K
PHR icon
69
Phreesia
PHR
$773M
$1.88M 0.03%
111,270
+34,750
+45% +$717K
IIIV icon
70
i3 Verticals
IIIV
$342M
$1.84M 0.03%
72,902
+3,350
+5% +$94.3K
ERII icon
71
Energy Recovery
ERII
$443M
$1.8M 0.03%
133,725
+3,355
+3% +$50.9K
TWST icon
72
Twist Bioscience
TWST
$7.25B
$1.8M 0.03%
56,785
+1,185
+2% +$37K
ONT
73
Onterris Inc
ONT
$580M
$1.77M 0.03%
71,475
+1,795
+3% +$47.4K
PL icon
74
Planet Labs
PL
$8.53B
$1.64M 0.03%
82,985
-163,250
-66% -$2.34M
COCO icon
75
Vita Coco
COCO
$3.6B
$1.57M 0.03%
29,675
-15,875
-35% -$745K

Similar funds

Conestoga Capital Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Conestoga Capital Advisors held 127 positions worth $5.94B, down 4.6% from $6.23B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Conestoga Capital Advisors withdrew a net $192M in Q4 2025, closing 6 positions and reducing 62 holdings. Its most notable exit was Trex, an estimated $97.9M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 44% of assets, down from 44% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Conestoga Capital Advisors opened a new position in Karman Holdings worth $39.1M.

  • Conestoga Capital Advisors's largest Q4 2025 buy was Karman Holdings: 534,897 shares worth $39.1M.
  • Conestoga Capital Advisors added most to Bright Horizons in Q4 2025, an estimated $22.2M increase.
  • Conestoga Capital Advisors's biggest Q4 2025 reduction was SPS Commerce, cutting an estimated $59.2M.
  • Conestoga Capital Advisors fully exited Trex in Q4 2025, selling an estimated $97.9M.
  • Conestoga Capital Advisors's ten largest holdings make up 35% of its $5.94B portfolio in Q4 2025.
  • Conestoga Capital Advisors opened 5 new positions and closed 6 in Q4 2025.
  • Conestoga Capital Advisors's portfolio value fell 4.6% quarter-over-quarter to $5.94B.

Based on Conestoga Capital Advisors's 13F filing for Q4 2025, filed 2 Feb 2026.